n-monodemethyldiltiazem has been researched along with midazolam in 2 studies
Studies (n-monodemethyldiltiazem) | Trials (n-monodemethyldiltiazem) | Recent Studies (post-2010) (n-monodemethyldiltiazem) | Studies (midazolam) | Trials (midazolam) | Recent Studies (post-2010) (midazolam) |
---|---|---|---|---|---|
30 | 3 | 1 | 9,834 | 3,191 | 3,301 |
Protein | Taxonomy | n-monodemethyldiltiazem (IC50) | midazolam (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 2.7427 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalvie, D; Loi, CM; Smith, DA | 1 |
Gorski, JC; Hall, SD; Jones, DR; Quinney, SK; Zhang, X | 1 |
1 trial(s) available for n-monodemethyldiltiazem and midazolam
Article | Year |
---|---|
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
Topics: Administration, Oral; Adult; Biotransformation; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Intestinal Absorption; Intestines; Liver; Male; Midazolam; Models, Biological; Nonlinear Dynamics; Prospective Studies; Reproducibility of Results; Young Adult | 2009 |
1 other study(ies) available for n-monodemethyldiltiazem and midazolam
Article | Year |
---|---|
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |